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Abstract The addition of a poly-His C-terminal extension, 
designed to facilitate the purification of the protein, to the 
pMactamase of a thermophilic Bacillus liclteniformis strain 
modified the site of action of the signal peptidase. This resulted 
in the secretion of a protein with a different N-terminus, showing 
that this type of protein engineering might not always be as 
'neutral' as generally assumed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The addition of poly-His terminal extensions, designed to 
allow the easy purification of the target protein on a metal-
chelating gel, has become a standard practice in molecular 
biology. In this study, we produced and purified a (5-lactamase 
from a thermophilic Bacillus licheniformis strain [1] with and 
without a poly-His C-terminal extension and observed an un-
expected modification of the cleavage site of the signal peptide 
in the latter. 
2. Materials and methods 
2.1. Recombinant DNA techniques, bacterial strains, plasmids and 
growth conditions 
The procedures used were essentially those described by Sambrook 
et al. [2]. The BS3 strain, isolated from a traditional hot bath in the 
Meknes area (Morocco) was grown in liquid M4 medium at 50°C [1]. 
The genomic DNA was extracted as described in [3]. The cloning 
experiments were performed in E. coli RRI or Top 10 F' as hosts 
[4,5] using the PUCRM20 vector [6,7] from Boehringer (Mannheim, 
F.R.G.). The E. coli overexpression strains BL21DE3 or 
HMS174DE3 [8] were from Novagen, Oxon, UK. The ampicillin re-
sistance gene of the pET22b plasmid (Novagen) was inactivated by 
insertion of a Kanamycin resistance cartridge (Pharmacia, Roosen-
daal, The Netherlands) at the Pstl site. The resulting vector 
(pET22bKr) was used to overproduce the BS3 pi-lactamase. 
Kanamycin, chloramphenicol or ampicillin were added to growth 
media at 50 n,g ml - 1 , 30 ug ml - 1 or 50 ug ml - 1 , respectively. 
2.2. Identification of the strain 
Identification of the Bacillus BS3 strain was performed at the 
BCMM/LMG Culture Collection, Laboratorium voor Microbiologie, 
Universiteit Gent, Belgium, on the basis of an ARDRA test [9], a 
fatty acid analysis and an API test. All the criteria identified the 
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isolate as a Bacillus licheniformis strain with excellent identification 
scores. 
2.3. Oligonucleotides and PCR experiments 
The oligonucleotides were purchased from Eurogentec (Liege, Bel-
gium). Their sequences were deduced from that of the B. licheniformis 
749/Cbla gene obtained by Neugebrauer et al. [10]. Further details on 
the molecular biology and sequencing techniques are available from 
the authors. 
2.4. Protein purification and enzyme chemistry 
The Q-Sepharose and Mono-S columns were from Pharmacia (Up-
psala, Sweden) and the Ni2 ' -nitrilotriacetate-agarose column from 
Affiland (Ans, Belgium). The kinetic parameter were determined as 
described previously [1,11]. All experiments were performed at 30°C in 
50 mM sodium phosphate, pH 7. Thermal unfolding curves were 
obtained as previously described [12] in 50 mM sodium acetate 
(pH 5), 50 mM sodium phosphate (pH 7) and 50 mM glycine/ 
NaOH (pH 9) buffers. 
2.5. Internal peptide isolation 
After gel electrophoresis of a 30 pmol sample, the enzyme was 
transferred to a nitrocellulose membrane with the help of a Bio-Rad 
Semi-dry DB Trans-Blot SD and hydrolysed by the Lys-C endopro-
teinase (10% w/w) during 24 h at 37°C. The peptides were purified by 
HPLC on a Reverse Phase column and the sequence determined with 
10 pmoles of each peptide. 
2.6. Sequence analysis 
N-Terminal sequence analysis was carried out on a pulsed-liquid 
sequenator with on-line analysis of the PTH-amino acids (Perkin El-
mer, Applied Biosystems Division, Foster City, CA). C-Terminal se-
quencing was performed on a Procise 494C sequencer (Perkin Elmer) 
using a slight modification of the protocol described by Boyd et al. 
[13], The alkylated thiohydantoins were identified by reversed phase 
HPLC [13], Prior to sequence analysis, the lysine side chains were 
modified with phenylisocyanate under basic conditions [14]. 
2.7. Mass spectrometry 
Electrospray ionisation mass spectrometry was carried out on a 
Bio-Q quadrupole mass spectrometer (Micromass, Altrincham, UK). 
Ten microliters of a sample solution in 50% acetonitrile/1% formic 
acid were injected manually in the 20 u.1 loop of the Rheodyne injector 
and pumped with a Harvard syringe pump (South Natick, MA) at 
a flow rate of 5 ul/min. Scans of 9 s over the mass range of 600-
1500 a.m.m were collected over 2 min. Mass calibration was done 
with horse heart cytochrome c. 
2.8. Crystallographic techniques 
The initial crystallization conditions for the rBS3 p-lactamase were 
determined using the Gridscreen, Crystal Screen and Crystalscreen II 
sparse matrix crystallization screening kits (Hampton Research). 
The best crystals were obtained using the hanging drop vapour 
diffusion method from drops containing 5 ul of protein solution 
(10 mg/ml) and 5 ul of 25% PEG 6000 in 100 mM sodium acetate 
buffer pH 5.0, equilibrated against 1 ml of the latter solution at 20°C. 
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Diffraction intensities were collected using a Siemens XI000 area 
detector system using FRAMBO/ASTRO collection software. The 
X-ray source was a graphite-monochromated CuKa radiation pro-
duced by a Rigaku RU-200 rotating-anode generator operating at 
40 kV and 80 mA. The detector was positioned at 130 mm from 
the crystal. Intensities from 500 frames were recorded. In a single 
frame, reflections resulting from a 0.3° oscillation of the crystal 
were recorded in 90 s. A single crystal yielded a complete dataset 
with a total of 40503 observations to 2.4 A. Data evaluation was 
done with SAINT [15]. 
3. Results 
3.1. Cloning and sequencing 
Since the N-terminus of the enzyme purified from the cul-
ture supernatant of Bacillus BS3 appeared to be blocked, the 
protein was digested with the Lys-C endopeptidase. Four in-
ternal peptides were sequenced and found to correspond to 
analogous peptides in the B. licheniformis 749/C (3-lactamase 
with only two mutations. 
In consequence, a PCR experiment was performed with 
1.5 u,g of genomic BS3 DNA and primers corresponding to 
nt 392^-10 and 1167-1186 in the sequence of the B. licheni-
formis 749/C gene, yielding the expected 820-bp product. Sev-
eral templates were completely sequenced on both strands. 
The sequence, available under the Y10006 accession number 
in the EMBL bank revealed 36 mutations when compared to 
that of the 749/C gene, generating the 7 following modifica-
tions in the primary structure of the protein: A59T, A133T, 
V187A, R191Q, D227E, A238G and M287V (ABL number-
ing, [16]). Two of these (A133T and A238G) are located in the 
vicinity of the active site (Fig. 1). 
3.2. Overproduction 
For overproduction and purification of the protein, two 
strategies were utilized. The protein was produced both with 
and without a C-terminal (HisVtag. PCR reactions yielded 
the genes encoding respectively the protein with the wild-type 
C-terminus or with an eleven residue A3LEH6 C-terminal ex-
tension, as a result of cloning between the Mscl and Not! 
restriction sites in pET22bKr. In both cases, the signal peptide 
was that of pullulanase (pelB) present in the expression plas-
mid and the first residue of the periplasmic, mature protein 
was expected to be Lys26. Good production was obtained with 
BL21DE3 cells grown at 37°C, induced at an Amo value of 1.0 
with 1 mM IPTG during 3 h. About 10 mg of enzyme exhib-
iting the wild-type C-terminus were purified to homogeneity 
by Q-Sepharose chromatography at pH 7.2 from 1 liter of 
culture. The rBS3 protein exhibited the expected N-terminal 
sequence (KTEMKDDEAK) and the Mr value measured by 
ESMS was 29476.8 ± 2 in excellent agreement with that of the 
265 residue polypeptide deduced from the gene sequence 
(29475). The periplasmic fraction containing the His-tagged 
protein was purified on Ni2+-NTA agarose but only 50% of 
the enzymatic activity was retained by the column. A new 
periplasmic extract was purified by Q-Sepharose chromatog-
raphy, yielding upon SDS-PAGE, a doublet of proteins with 
very similar apparent Mr values, which could be separated as 
two fractions of identical specific activities by FPLC on a 
Mono S column at pH 4.5. The two proteins exhibited iden-
tical N-terminal sequences (AAQPAMAKTEM) where the 
first seven residues corresponded to the seven last residues 
of the pelB signal peptide. This indicated an incorrect N-ter-
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Fig. 1. Alpha-carbon trace (Molscript, [19]) of the B. licheniformis 
749/C p-lactamase (PDB entry code 4BLM). The positions of the 
residues which are different in the BS3 are labelled. 
minal processing of the proteins and suggested a heterogene-
ous C-terminus. 
C-Terminal sequencing of the first fraction (A) revealed the 
sequence -MNGKAAAL with some contamination (about 
20%) by the sequence -MNGKA. C-Terminal sequence anal-
ysis of the second fraction (B) also yielded the above major 
sequence, but with a much lower initial yield than for fraction 
A (13 vs 143 pmoles). However, a Glu residue was also de-
tected at degradation step 7. Since the chemistry of the C-ter-
minal sequence analysis so far does not allow to reproducibly 
identify the His residue, it was concluded that the Glu could 
only be the residue preceding the 6 histidines of the His-tag 
sequence and that this was the major polypeptide in fraction 
B. This conclusion is corroborated by the fact that the major 
peaks in the electrospray spectra of fractions A and B differed 
by 952.0 Da which is nearly identical to the theoretical mass 
of the sequence EH6 (951.0 Da). 
3.3. Properties of the recombinant enzymes 
Within the limits of experimental errors, the Km values for a 
set of 2 penicillin and 5 cephalosporin substrates were not 
significantly different from those of the original enzyme. The 
&cat values were 2-3-fold higher with the recombinant pro-
teins, which could be explained by a loss of activity of the 
WT enzyme upon storage of rather dilute solutions, a situa-
tion which often results in progressive denaturation. The ki-
netic properties of the rBS3 enzyme were also very similar to 
those of the 749/C P-lactamase, the only significant differences 
being observed with cefazolin (6-fold decrease of kc&JKm), 
7-amino cephalosporanic acid and cefotaxime (6- and 10-
fold increase, respectively). 
Thermal unfolding, monitored at pH 5, 7 and 9 was fully 
reversible in all cases. The rBS3 protein exhibited a Tm value 
of 64.7°C, very close to that (64.4°C) observed with the WT 
enzyme. The two other proteins with the N- and C-terminal 
extensions were somewhat less stable, exhibiting Tm values 
lowered by 1.4 to 3.0°C depending upon the conditions. 
3.4. Preliminary crystallographic data 
Crystals of the rBS3 protein grew as thin and twinned 
plates or as hollow elongated needles. Larger prisms 
(0.6X0.15X0.15 mm) diffracting to 2.4 A were obtained by 
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adding 1% of re-octyl-P-A-glucoside. X-ray data collected with 
the area detector and processed with the SAINT software 
indicated that the crystals belong to space group P2i2i2i 
with unit-cell dimensions a = 54.97 A, b = 87.03 A and 
c- 110.76 A. The R factor for merging data was 11.9%. The 
structure of the BS3 P-lactamase will be solved by molecular 
replacement, using the refined structure of the B. licheniformis 
749/C P-lactamase (PDB entry code 4BLM) as starting model. 
4. Discussion 
The properties of the rBS3 enzyme were very similar to 
those of the B. licheniformis 749/C P-lactamase [11]. The 
rBS3 protein was somewhat more heat-stable than its 749/C 
counterpart (ATm = 1.5°C), which makes it the most heat-sta-
ble serine P-lactamase isolated so far. Solving the 3D structure 
of the rBS3 enzyme might supply clues to the understanding 
of these small differences. 
The addition of a C-terminal poly-His tag, designed to fa-
cilitate the purification, resulted in a modified processing of 
the N-terminus of the protein. As shown by Fig. 1, the N- and 
C-termini of the folded protein are very close to each other 
and the C-terminal extension clearly affects the site at which 
the signal peptidase exerts its activity. This also demonstrates 
that the latter enzyme liberates the soluble extracellular pro-
tein after it has acquired a native or near native structure. The 
observed heterogeneity of the C-terminal extension could be 
due to a periplasmic protease, specific for non-polar C-termini 
and designated Tsp [17] or Pre [18]. The addition of a poly-
His tag has become a rather common practice in molecular 
biology, most often when the target protein is produced in 
small quantities and difficult to purify. Our results should 
serve as a warning that this addition might not always be as 
'neutral' as usually assumed. In the present case, the modified 
processing did not seriously influence the functional properties 
of the protein, but this should not be taken as granted. In 
consequence, a careful comparison of the wild-type and 'His-
tagged' proteins remains necessary to avoid the dangers of 
blindly assuming that the latter always behave exactly as the 
former. 
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